Search results for "Clero"

showing 10 items of 2052 documents

Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis

1998

SUMMARY Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Recent studies have shown that genetic factors and both cellular and humoral immunological abnormalities are important in the pathogenesis of PSC. The most prominent autoantibodies in PSC are anti-neutrophil cytoplasmic antibodies (ANCA). The autoepitopes of ANCA in PSC are not well defined. The aim of this study was to identify corresponding ANCA autoantigens in patients with PSC. A biochemical approach with enrichment and partial purification of soluble neutrophil proteins, detection of autoantibodies by Western blot and partial amino acid sequencing were used. Two new autoantigen/aut…

endocrine system diseasesAlpha-enolaseBlotting WesternCholangitis SclerosingMolecular Sequence DataImmunologyAutoimmunityEnzyme-Linked Immunosorbent Assaymedicine.disease_causedigestive systemAutoimmunityPrimary sclerosing cholangitisAntigenWestern blotmedicineHumansImmunology and AllergyAmino Acid SequenceAutoantibodiesAnti-neutrophil cytoplasmic antibodybiologymedicine.diagnostic_testdigestive oral and skin physiologyAutoantibodyOriginal ArticlesCatalasemedicine.diseasedigestive system diseasesPhosphopyruvate HydrataseImmunologybiology.proteinAntibodyClinical and Experimental Immunology
researchProduct

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

2009

Type 2 diabetes is a chronic, progressive disease with a multi-faceted pathophysiology. Beyond the known defects of insulin resistance and beta-cell insufficiency, derangement of incretin hormones normally produced from the gut wall in response to food intake play an important role. In recent years, the 'incretin-based' therapies (IBTs) have been developed to address hyperglycemia through either mimicking the action of the endogenous incretin glucagon-like polypeptide (GLP-1) (GLP-1 receptor agonists) or by inhibiting the activity of the enzyme that degrades GLP-1 (the dipeptyl peptidase-4 inhibitors).We reviewed available evidence on the glucose lowering and anti-atherogenic effects of IBT…

endocrine systemmedicine.medical_specialtyDipeptidyl Peptidase 410265 Clinic for Endocrinology and DiabetologyIncretin610 Medicine & healthType 2 diabetesCarbohydrate metabolismIncretinsInsulin resistancecardiovascular risk diabetes DPP-4 inhibitors GLP-1 analoguesGlucagon-Like Peptide 1Risk FactorsInternal medicineDiabetes mellitusmedicineAnimalsHumans2736 Pharmacology (medical)Pharmacology (medical)Dipeptidyl peptidase-4PharmacologyClinical Trials as TopicDipeptidyl-Peptidase IV Inhibitorsbusiness.industrydigestive oral and skin physiologyGeneral MedicineAtherosclerosismedicine.diseaseGlucose3004 PharmacologyEndocrinologyPostprandialDiabetes Mellitus Type 2aterosclerosibusinesshormones hormone substitutes and hormone antagonistsHormoneExpert Opinion on Investigational Drugs
researchProduct

Sildenafil inhibits the proliferation of cultured human endothelial cells.

2013

The proliferation of endothelial cells plays a crucial role in the development of intraplaque angiogenesis (IPA). IPA is a major source of intraplaque hemorrhage and therefore contributes to the destabilization of atherosclerotic plaques. Therefore, the aim of the present study was to examine, whether sildenafil inhibits endothelial cell growth. The proliferation of human endothelial cells derived from umbilical cord veins (HUVEC) was examined on DNA level by measurements of (3H)-thymidine incorporation. Cell viability was analyzed using trypan blue staining. The proliferation of cultured human endothelial cells was significantly decreased by 1 μmol/l (-48.4%) and 10 μmol/l (-89.6%) sildena…

endothelial proliferationsildenafilcardiovascular systematherosclerosisbasic fibroblast growth factorArticleplaque angiogenesisrespiratory tract diseasesInternational journal of biomedical science : IJBS
researchProduct

Estrogen Receptor and Vascular Aging.

2021

Cardiovascular diseases remain an age-related pathology in both men and women. These pathologies are 3-fold more frequent in men than in women before menopause, although this difference progressively decreases after menopause. The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated. In this review, we will attempt to summarize the main clinical and experimental studies reporting the protective effects of estrogens against cardiovascular diseases, with a particular focus on atherosclerosis, and the impact of aging and estrogen deprivation on their endothelial actions. Th…

endotheliumvascular agingGeriatricsestradiolRC952-954.6menopauseGeneral Medicineatherosclerosisestrogen receptorFrontiers in aging
researchProduct

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

2010

Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no majo…

endovascular treatmentAdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentmedicine.medical_treatmentFemoral veinBalloonYoung AdultPostoperative ComplicationsCentral Nervous System DiseasesAngioplastymedicineHumansVeinAgedbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryVenous thrombosisChronic cerebrospinal venous insufficiencymedicine.anatomical_structureVenous InsufficiencyChronic DiseaseFemaleStentsRadiologyCardiology and Cardiovascular MedicineVenous malformationbusinessvenous malformationAngioplasty BalloonMagnetic Resonance AngiographyPhlebology: The Journal of Venous Disease
researchProduct

La periodontitis como factor de riesgo en los pacientes con cardiopatía isquémica

2004

La patología cardiovascular y en especial la cardiopatía isquémica (CI) se encuentran entre las principales causas de muerte en el mundo occidental. Recientemente se ha incrementado el interés en investigar la relación entre la cardiopatía isquémica y diversas patologías infecciosas como desencadenantes de la misma, como se ha observado con la Clamydia pneumoniae y el Helicobacter pylori. La periodontitis también se ha relacionado con el incremento de riesgo de aparición de enfermedad coronaria, debido a que ambas patologías presentan algunas características comunes como la edad, el sexo y el hábito tabáquico entre otras. Existen muchas similitudes entre la patología vascular inducida por b…

enfermedad coronariaOdontologíaOral medicineMalalties periodontalsMalalties de la boca:CIENCIAS MÉDICAS [UNESCO]Malalties coronàriesAtherosclerosisCiencias de la saludCoronary diseasesMouth diseasescardiopatía isquémicaUNESCO::CIENCIAS MÉDICASEstomatologiaaterosclerosisPeriodontal diseasePeriodontitisAterosclerosi
researchProduct

Inmunidad Innata en Esclerosis Múltiple Progresiva: Papel de la Chitinase 3-like 1

2020

Introducción: La esclerosis múltiple (EM) es una enfermedad heterogénea en la que coexisten dos fenómenos: la inflamación, que se manifiesta en forma de brotes, y la progresión sostenida de la discapacidad. Es necesario identificar biomarcadores que permitan detectar la neurodegeneración subyacente a la progresión desde el inicio, pues se pone de manifiesto de forma tardía. La Chitinase 3-like 1 (CHI3L1) se ha relacionado con la progresión en la EM, pero su papel en la patogenia de la enfermedad es todavía desconocido. Objetivos: En este trabajo, estudiamos los niveles de CHI3L1 y de la Cadena ligera de Neurofilamento (NfL) en el líquido cefalorraquídeo (LCR) de pacientes con EM y analizamo…

enfermedades desmielinizantesesclerosis múltipleneuromielitis ópticachitinase 3-like 1UNESCO::CIENCIAS MÉDICASneuroinmunologiaencefalomielitis aguda diseminada:CIENCIAS MÉDICAS [UNESCO]
researchProduct

A rare complication of idiopathic osteosclerosis

2007

Idiopathic osteosclerosis (IO) is described as a localized no expansible radiopacity with unknown etiology. The IO is generally asymptomatic and could appear as round, elliptical or irregular in shape. The internal aspect is usually uniformly radiopaque. IO should be distinguished from condensing osteitis of dental origin, or other alveolar bone related radiopacities such as periapical cemental dysplasia. This condition may cause changes in tooth position or problems during orthodontic treatment. The purpose of the present study is to report a case of tooth resorption caused by ectopic eruption rote caused by IO. This condition represents a rare complication of IO.

eruptionorthodonticUNESCO::CIENCIAS MÉDICAS:CIENCIAS MÉDICAS [UNESCO]radiopaqueOsteosclerosis
researchProduct

Valor del grosor de la capa de fibras nerviosas de la retina medido mediante tomografía de coherencia óptica como marcador de daño neuroaxonal en la …

2012

Estudio del valor del grosor de la Capa de Fibras Nerviosas de la Retina (CFNR) a lo largo de un año como marcador de daño neuroaxonal en pacientes con distintos estadios de Esclerosis Múltiple (EM): pacientes con síndrome clínico aislado (CIS) que es el estadio más inicial de enfermedad desmielinizante, pacientes con esclerosis múltiple remitente-recurrente (EMRR) y pacientes con esclerosis múltiple primaria-progresiva (EMPP) frente a sujetos sanos. Estudio de las posibles correlaciones existentes con otros parámetros como la latencia de la onda P100 de los potenciales evocados visuales (PEV) como marcador de desmielinización, con el volumen cerebral de sustancia gris y de sustancia blanca…

esclerosis múltiple:CIENCIAS MÉDICAS ::Ciencias clínicas::Oftalmología [UNESCO]tomografía de coherencia ópticaUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::Oftalmología:CIENCIAS MÉDICAS ::Otras especialidades médicas [UNESCO]capa de fibras nerviosas de la retinaUNESCO::CIENCIAS MÉDICAS ::Otras especialidades médicassíndrome clínico aislado
researchProduct

Factores pronósticos en el síndrome clínico aislado de origen desmielinizante

2023

INTRODUCCIÓN: El síndrome clínico aislado (SCA) de origen desmielinizante es, en la mayoría de los casos, la primera manifestación clínica de la esclerosis múltiple (EM). Se trata de una enfermedad neurológica con una evolución muy heterogénea. El grado de discapacidad que provoca depende fundamentalmente del inicio de la fase secundaria progresiva (EMSP). La resonancia magnética (RM) y el estudio del líquido cefalorraquídeo (LCR) son las pruebas más utilizadas en el estudio del SCA y podrían informar del pronóstico a largo plazo y de los procesos que favorecen la EMSP. OBJETIVO: Conocer el valor pronóstico de los distintos factores demográficos y clínicos presentes en los pacientes con SCA…

esclerosis múltipleUNESCO::CIENCIAS MÉDICASsíndrome clínico aislado
researchProduct